Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I
crease in HDL, whereas hepatic overexpression of scavenger receptor (SR)-BI with gene
transfer reduces atherosclerosis, despite a major reduction in HDL levels. 47, 48 …
transfer reduces atherosclerosis, despite a major reduction in HDL levels. 47, 48 …
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins-An idea whose time for testing is coming, Part II
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - lup.lub.lu.se
Despite the benefits of currently available preventative and therapeutic interventions,
atherosclerotic vascular disease continues to be a major cause of morbidity and mortality in …
atherosclerotic vascular disease continues to be a major cause of morbidity and mortality in …
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - pubmed.ncbi.nlm.nih.gov
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an
idea whose time for testing is coming, part II Exploiting the vascular protective effects of …
idea whose time for testing is coming, part II Exploiting the vascular protective effects of …
[引用][C] Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins. An idea whose time for testing is coming, part I
PK SHAH, S KAUL, J NILSSON… - Circulation (New York …, 2001 - pascal-francis.inist.fr
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins.
An idea whose time for testing is coming, part I CNRS Inist Pascal-Francis CNRS Pascal …
An idea whose time for testing is coming, part I CNRS Inist Pascal-Francis CNRS Pascal …
[引用][C] EXPLOITING THE VASCULAR PROTECTIVE EFFECTS OF HIGH-DENSITY LIPOPROTEIN AND ITS APOLIPOPROTEINS: AN IDEA WHOSE TIME FOR …
PK SHAH, S KAUL, J NILSSON - 2001 - sid.ir
[PDF][PDF] From Bench to Bedside
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - Citeseer
by guest on March 2, 2014 http://circ. ahajournals. org/Downloaded from crease in HDL,
whereas hepatic overexpression of scavenger receptor (SR)-BI with gene transfer reduces …
whereas hepatic overexpression of scavenger receptor (SR)-BI with gene transfer reduces …
[引用][C] Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - cir.nii.ac.jp
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[引用][C] Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II.
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - europepmc.org
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins:
an idea whose time for testing is coming, part II. - Abstract - Europe PMC Sign in | Create an …
an idea whose time for testing is coming, part II. - Abstract - Europe PMC Sign in | Create an …
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins-An idea whose time for testing is coming, Part II
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - portal.research.lu.se
Despite the benefits of currently available preventative and therapeutic interventions,
atherosclerotic vascular disease continues to be a major cause of morbidity and mortality in …
atherosclerotic vascular disease continues to be a major cause of morbidity and mortality in …
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II
PK Shah, S Kaul, J Nilsson, B Cercek - Circulation, 2001 - Am Heart Assoc
tein J–containing HDL subspecies. 7, 11–31 The cholesterol efflux–promoting capacity is
generally attributed to subspecies containing apolipoprotein AI. 32–38 Several naturally …
generally attributed to subspecies containing apolipoprotein AI. 32–38 Several naturally …